Skip to Content

Twynsta Approval History

  • FDA approved: Yes (First approved October 16th, 2009)
  • Brand name: Twynsta
  • Generic name: telmisartan and amlodipine
  • Dosage form: Tablets
  • Company: Boehringer Ingelheim Pharmaceuticals Inc.
  • Treatment for: High Blood Pressure

Twynsta (telmisartan/amlodipine) is an angiotensin II receptor blocker (ARB) and a dihydropyridine calcium channel blocker (DHP-CCB) combination product indicated for the treatment of hypertension alone or with other antihypertensive agents.

Development History and FDA Approval Process for Twynsta

Oct 19, 2009Approval FDA Approves Twynsta (telmisartan/amlodipine) for Hypertension

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.